Latest News for MKKGY
Shares of Merck KGaA (OTCMKTS:MKKGY - Get Free Report) have been given an average recommendation of "Hold" by the six analysts that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a hold recommendation. A number of research analysts recently issued reports on the stock. HSBC upgraded shares of Merck
Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript
Merck KGaA (MKKGY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.57 per share a year ago.
BAAR, Switzerland--(BUSINESS WIRE)--Evinova, a global leader in AI-native clinical development technology, today announced a new multi-year strategic collaboration to accelerate global clinical development with Merck KGaA, Darmstadt, Germany, a leading science and technology company. Merck KGaA, Darmstadt, Germany will adopt the end-to-end capabilities of the Evinova AI-Native platform covering all modules of study…
Merck KGaA (MKKGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for MKKGY.
Senate Trading
No Senate trades found for MKKGY.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.